NEW YORK ( TheStreet) - Pfizer (PFE - Get Report), Watson Pharmaceuticals (WPI) and Mednax (MD - Get Report) are among the eight stocks reporting quarterly earnings next week.
, with minimum market capitalization of $1 billion, have upside potential ranging from 9% to 34%. On average, 66% of analysts have buy ratings on these stocks, and another 33% have hold ratings.
The stocks are listed below in order of their earnings release dates and upside potential.
(PFE - Get Report)
is a research-based global pharmaceutical company operating in two segments: biopharmaceutical and diversified. The company's diversified portfolio includes human and animal health products as well as nutritional products. Pfizer will announce third-quarter results on Nov. 1.
For 2011 third quarter, net income is estimated at $4.35 billion on sales of $16.48 billion, vs. net income of $4.37 billion recorded on $16.17 billion sales for the same period prior year, as per analysts polled by
. Earnings per share are forecast at 56 cents for the quarter, against 54 cents in 2010 third quarter. Gross margin for the period is pegged at 80.20% as compared to 75.91% in the year-earlier period.
The company's board has approved its fourth-quarter dividend of 20 cents on common stock payable Dec. 6.
Of the 28 analysts covering the stock, 71% recommend a buy and 21% a hold. Analysts polled by
expect the stock to gain an average 15.1% to $22.84 from current levels over the next 12 months.